NL-OMON48963RecruitingNot Applicable
Stratifying Cystic Fibrosis Patients Based on Intestinal Organoid Response To Different CFTR-modulators - Part 1 HIT-CF project: Organoid Study
niversitair Medisch Centrum Utrecht0 sites75 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •1. Male or female with confirmed diagnosis of CF. The subject must have of the following:
- •o One or more characteristic phenotypic features, such as chronic cough and sputum production, persistent chest radiograph abnormalities, or airway obstruction manifested by wheezing and air trapping; or a history of CF in a
- •sibling ; or a positive new-born screening test result;
- •2. An increased sweat chloride concentration (above 60 mmol/L) by pilocarpine iontophoresis (documented in patient records)
- •3. Adult age* on the date of informed consent for biopsy taking. Younger patients will not be included due to extensive and long-term safety data needed before a trial in younger paediatric patients is considered safe.
- •*16 or 18 years depending on country-specific ethical regulations
- •4. Subject will sign and date an informed consent form (ICF).
Exclusion Criteria
- •1. Subject has at least one of the following CFTR-mutations:
- •508del, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R, R117H, A455E, 3849+10kbC>T
- •2. Subject has a combination of any two (2) of the following mutations:
- •G542X, 1717-1G>A, 621+1G>T, 3120+1G>A, 1898+1G->A, CFTRdele2,3 and 2183AA->G
- •3. History of any comorbidity reviewed at the Screening Visit that, in the opinion of the investigator, might pose an additional risk in potentially administering study drug to the subject if he or she enters the subsequent clinical study. For example, a history of cirrhosis with portal hypertension.
- •4. History of lung transplantation.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Treatment of patients with cystic fibrosis with N-acetylcysteineEUCTR2007-001401-15-DKRigshospitalet
Completed
Not Applicable
Observation of the treatment of cystic fibrosis patients with Pseudomonas aeruginosa lung infection with ColiFin 1Mio I.E. or ColiFin 2Mio I.E.Chronic infection with Pseudomonas aeruginosaCystic fibrosisE84B96.5Pseudomonas (aeruginosa) as the cause of diseases classified to other chaptersCystic fibrosisDRKS00009540PARI Pharma GmbH32
Recruiting
Not Applicable
HIT-CF Organoid Study: Stratifying Cystic Fibrosis Patients Based on Intestinal Organoid Response To Different CFTR-modulatorsNL-OMON24027niversity Medical Center Utrecht500
Recruiting
Not Applicable
Respiratory mechanics parameters of children and adolescents with Cystic Fibrosis: response to the forced expiration techniqueC06.689.202Cystic FibrosisRBR-2zsbgdniversidade do Estado de Santa Catarina - UDESC
Recruiting
Not Applicable
Cough and diaphragmatic breathing exercise: is there airway repercussion in children with cystic fibrosis?C06.689.202Cystic FibrosisRBR-4stzq4Hospital Infantil Joana de Gusmão